home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Cell & Gene Therapy Research & Development Congress Asia 2020

 
  February 20, 2020  
     
 


Global Engage Sdn Bhd Asia Pacific Office, Taipei, Taiwan
20-21st October 2020


This 2-day conference will focus on the advances being made in cell and gene therapies which have rapidly become an integral and vital component of modern medicine.  With more than 30 presentations this event will provide a platform for leading biopharma and biotech leaders, academicians and researchers to discuss topics on

·         emerging advances in the field of cell and gene therapy

·         the regenerative potential of stem cells

·         application of T- cells and Cart-T in the field of immuno-oncology

·         novel gene-editing tools and delivery methods

·         vector development

·         regulatory approaches

·         ethical considerations and more.

 
 
Organized by: Global Engage Sdn Bhd Asia Pacific Office
Invited Speakers:

Speakers for Cell & Gene

 

  1. Anthony Colenburg, Director of Quality, Adicet Bio, USA

 

  1. Thai-Yen Ling, Associate Professor, National Taiwan University, Taiwan

 

  1. Yu Chen Hu, Professor, National Tsing Hua University, Taiwan

 

  1. Yen-Chung Chen, R&D Director, Maria Von Med-Biotechnology, Taiwan

 

  1. Jaeseung Lim, CEO, Cellatoz Therapeutics, Korea

 

  1. Rajarshi Pal, Chief Scientist, Eyestem Research, India

 

  1. Franco Marincola, Chief Scientific Officer, Refuge Biotechnology Inc, USA

 

  1. ChiaChe Tsai, Head of R&D & VP, UnicoCell, Taiwan

 

  1. Frank Fan, CSO & Founder, Legend Biotech, China

 

  1. Sandy Qlintang, Director, Stem Cell and Cancer Institute, PT Kalbe, Indonesia

 

  1. Robson Dossa, Associate Director, Kite Pharma, USA

 

  1. Wei-Kuang Chi, Vice President of R&D, Development Center for Biotechnology, Taiwan

 

  1. Ing Ming Chiu, Professor & Distinguished Investigator, National Health Research Institute, Taiwan

 

  1. Ting He, CEO, Immunochina Pharmaceuticals Co. Ltd., China
 
Deadline for Abstracts: 20.06.2020
 
Registration: Contact : saffuan@global-engage.com for registration and early-bird discount
E-mail: saffuan@global-engage.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2020 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.